Cannabis Science & Health
Synthetic Psychedelic Compounds May Treat Depression Without the Trip, Study Suggests
Scientists have developed a new compound which interacts with the same therapeutic targets in the brain as psychedelic drugs, producing the same long-lasting antidepressant and antianxiety effects but without the psychedelic high.
ASTM Approves Four New Cannabis Testing Standards
The leading US testing standards organization ASTM International has approved four new testing standards for cannabis samples.
California Regulator Offers $20 Million For Cannabis Research
California’s cannabis regulator will provide $20 million in funding for new cannabis-related research.
Researchers Create New CBD-Based Plastic
Researchers from the University of Connecticut and Purdue University report the creation of a new CBD-based bioplastic material.
Psychedelic Drugs: How to Tell Good Research From Bad
James Rucker, a consultant psychiatrist at King's College London, breaks down the good psychedelic research from the bad. via the Conversation.
Washington’s Cannabis Regulator Seeks Scientists
Washington’s state cannabis regulator is looking to recruit at least six experts in cannabis science to help advise the regulator on scientific matters.
Psychedelics Sector Must Respect Indigenous Wisdoms, Say Experts
The new essay highlights numerous ethical concerns currently facing the field and emphasizes the importance of acknowledging wisdoms already known to Indigenous people.
Ultrasound-Assisted Extraction is Ideal to Prepare Solid Edibles For Testing, Study Finds
Use ultrasound-assisted extraction to prepare solid edibles for analysis, and use solid-phase extraction for beverages, scientists recommend.
Ketamine Can Treat Depression By Altering a Person’s Beliefs, Study Suggests
Ketamine can help people with treatment-resistant depression by breaking their entrenched belief systems, according to a recent paper.
